PRME
Prime Medicine, Inc.
3.10$
+7.5%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 97.5% | 89.6% | 82.3% | 73.8% | 71.2% | 52.9% | |
| 99.4% | 67.5% | 61.4% | 52.1% | 21.4% | 61.3% | 18.4% | |
| 99.4% | 97.3% | 89.3% | 81.6% | 62.8% | 64.0% | 51.8% | |
| – | 1.1% | 5.2% | 5.3% | – | – | – | |
| 84.0% | 38.9% | 20.6% | 12.2% | 31.4% | 48.5% | 64.7% | |
| 84.0% | 35.5% | 19.2% | 7.4% | 29.1% | 12.8% | 10.9% | |
| – | 32.0% | 2.4% | 3.2% | 4.8% | 1.2% | 2.4% | |
| – | 0.5% | 0.5% | 1.2% | 10.1% | 3.8% | 2.6% | |
| 16.0% | 61.1% | 79.4% | 87.8% | 68.6% | 51.5% | 35.3% | |
| -29.9% | -11.0% | -56.8% | -81.4% | -253.5% | -231.0% | -259.2% | |
| 1,100.7% | 174.7% | 31.7% | 27.0% | 46.9% | 39.9% | 43.4% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.